AstraZeneca PLC (UK) Today
| AZN Stock | 11,784 62.00 0.52% |
PerformanceGood
| Odds Of DistressBelow Average
|
AstraZeneca PLC is trading at 11784.00 as of the 20th of March 2025, a 0.52 percent decrease since the beginning of the trading day. The stock's lowest day price was 11770.0. AstraZeneca PLC has about a 26 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat good performance during the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Moving together with AstraZeneca Stock
Moving against AstraZeneca Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
AstraZeneca Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AstraZeneca PLC's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AstraZeneca PLC or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Executive VicePresident | Menelas Pangalos |
| Business Concentration | Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
AstraZeneca PLC (AZN) is traded on London Exchange in UK and employs 94,300 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 183.57 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AstraZeneca PLC's market, we take the total number of its shares issued and multiply it by AstraZeneca PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AstraZeneca PLC operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 1.55 B outstanding shares.
AstraZeneca PLC generates positive cash flow from operations, but has no cash available
Check AstraZeneca PLC Probability Of Bankruptcy
Ownership AllocationAstraZeneca PLC holds a total of 1.55 Billion outstanding shares. Over half of AstraZeneca PLC's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in AstraZeneca PLC. Please watch out for any change in the institutional holdings of AstraZeneca PLC as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check AstraZeneca Ownership Details
AstraZeneca PLC Risk Profiles
Although AstraZeneca PLC's alpha and beta are two of the key measurements used to evaluate AstraZeneca PLC's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.9895 | |||
| Semi Deviation | 0.9334 | |||
| Standard Deviation | 1.36 | |||
| Variance | 1.84 |
AstraZeneca Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in AstraZeneca PLC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
AstraZeneca PLC Corporate Management
Elected by the shareholders, the AstraZeneca PLC's board of directors comprises two types of representatives: AstraZeneca PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AstraZeneca. The board's role is to monitor AstraZeneca PLC's management team and ensure that shareholders' interests are well served. AstraZeneca PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AstraZeneca PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marc Dunoyer | CEO Officer | Profile | |
| Pam Cheng | EVP Board | Profile | |
| MBA DVM | CEO Director | Profile | |
| Pr Belvisi | Respiratory, Dev | Profile | |
| Aradhana MD | CFO Director | Profile | |
| Katarina Ageborg | Chief Sustainability | Profile | |
| Jeffrey Pott | Chief CHRO | Profile |
Other Information on Investing in AstraZeneca Stock
AstraZeneca PLC financial ratios help investors to determine whether AstraZeneca Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AstraZeneca with respect to the benefits of owning AstraZeneca PLC security.